Navigation Links
Keryx Biopharmaceuticals Announces Additions to Management Team
Date:2/15/2008

Key Hires in Quality Operations and Medical Affairs

NEW YORK, Feb. 15 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Lou DeBergalis has joined the Company as Vice President, Quality Operations. Keryx also announced that Eric Grossman, MD, will join the Company later this month in the role of Vice President, Medical Affairs. Both Mr. DeBergalis and Dr. Grossman will report directly to Michael S. Weiss, Chief Executive Officer.

Commenting on the recent hires of Mr. DeBergalis and Dr. Grossman, Michael S. Weiss, the Company's Chairman and Chief Executive Officer, stated, "We are delighted to welcome Lou and Eric to the Keryx team. Each has exceptional experience in the pharmaceutical industry and brings a significant level of expertise to our quality operations and medical affairs as we continue to build the corporate infrastructure to manage both the potential launch of Sulonex and the future development and commercialization of our other drug candidates."

As Vice President, Quality Operations, Mr. DeBergalis will assume overall strategic and operational responsibility for all Quality Operations (clinical, non-clinical and manufacturing), including both quality control and quality assurance.

Mr. DeBergalis joins Keryx following his retirement from Pfizer Inc. in July 2007 as Vice-President Quality Operations - Europe/Ireland/Singapore, responsible for the operational, administrative, and regulatory aspects of quality in Pfizer's manufacturing sites in those geographic areas. During his 36 years in the Pfizer organization, Mr. DeBergalis held roles of increasing responsibility in both its Global Manufacturing and Quality Control Divisions in Pfizer's New York C
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
2. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
3. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
4. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
5. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
6. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
7. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
8. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
9. Nabi Biopharmaceuticals to Present at the BMO Capital Markets Focus on Healthcare Conference
10. China Biopharmaceuticals Holdings Announces Third Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals Stockholders Approve Asset Sale

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009).../PRNewswire-FirstCall/-HamiltonThorneLtd.(TSX-V:HT...vancedlasersystemsandinstrumentsforthestemcellrese...onalandfinancialresultsforthethirdquarterendedSept...46millioncomparedwith$1.43millioninQ32008,-Grosspr...3,2008,-Netlossreducedto$148,000comparedto$283,000...
(Date:11/24/2009)...HealthRoboticstodayannounced,thatithasformedanewCa...hisrecentlyformedToronto-basedcompanywilloperateun...install,andsupport,HealthRobotics,i.v.RoomoftheFut...feringsi.v.STATION(TM),i.v.SOFT(TM),andOMM(TM).,He...n"asneeded,basis"toitsstrategicpartnershipswithMcK...
(Date:11/23/2009)...cative new study, a University of Utah scientist a...jor cause of global warming cannot be stabilized ...ilds the equivalent of one new nuclear power plant... be any substantial near-term departure from recen...on rates," says the new paper by Tim Garrett, an a...
(Date:11/23/2009)...e-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: PDLI ...2009astheex-dividenddateforits$200millionspecialdi...transactioncompletedonNovember2,2009.Thedividendwi...ontherecorddate,December1,2009.NASDAQhassettheappr...fcommonstockforpurposesoftheex-dividenddateonNovem...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
...URY, N.J., Feb. 1 Amicus Therapeutics,Inc. (Nasda...President and,Chief Executive Officer, will presen...harmaceutical, Biotechnology & Medical Device Conf...08 at 11:40 am (Eastern Standard,Time) at the Gran...live and may be accessed by visiting,Amicus, websi...
... SAN FRANCISCO, Calif., Jan. 31 Rigel,Pharmaceuti...icing of its,public offering of 5,000,000 shares o... of the shares are being offered by Rigel. The und...tional 750,000 shares to cover,over-allotments, if...y 6,2008, subject to the satisfaction of customary...
...AM, Mass., Jan. 31 Inverness Medical,Innovations,...rketer of rapid,diagnostic products for the consum...it will attend the upcoming 2008 Merrill Lynch Glo...ce Conference being held,February 5 through 7, 200...wanziger, Chief Executive Officer, and Jon Russell...
Other Biology Technology:Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 2Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference 3Rigel Announces Pricing of Public Offering of Common Stock 2Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008 2
(Date:11/23/2009)...ccine available for the H1N1 virus has been sent t...The vaccination marks the first time vaccine has b...ic flu., Iowa State University,s Hank Harris, pr...his summer and has been shipping preventive doses ...r several weeks., The latest vaccines were shipp...
(Date:11/23/2009)...- A USDOE and USDA study concluded that 50 million...nd pasture could be converted from current uses to...chgrass, from which biomass could be harvested for...roduction of a perennial grass monoculture from wh...annually is expected to require nitrogen fertilize...
(Date:11/23/2009)...w Hampshire microbiologist Louis Tisa has received...ding of the actinorhizal plants, widespread woody ...contaminated soils. , The United States Departm...r of molecular, cellular and biomedical sciences, ...ween the bacteria Frankia and Casuarina, an actino...
Breaking Biology News(10 mins):Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Exercise helps patients with non alcoholic fatty liver disease 50560 1Exercise helps patients with non alcoholic fatty liver disease 50560 2Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 1Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 2Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 3Two New Dakim Sponsored Blogs Help Families Affected by Dementia 50554 1Two New Dakim Sponsored Blogs Help Families Affected by Dementia 50554 2
...l team of scientists from Canada (Universit Laval)...) and Spain (Do ana Biological Station), have disc...ast African cichlid fishes a group of fish whose ...ed evolutionary biologists for decades evolved di...n why they do not interbreed, despite living side ...
...-legged animals sprouted fingers and toes, they to...he cooking time, say University of Florida scienti...S ONE. , Even sharks which have existed for mo...ingers in their genetic cookbook not to eat them,...ms of development in shark embryos, UF scientists ...
... diet high in red meat, fatty products, refined gr...be increasing their chance of disease relapse and ...cer Institute. , The study, published in the Aug....ssociation, involved 1,009 patients with stage III...ery and chemotherapy. Stage III colon cancer is ch...
Other Biology News:Adaptation to parasites drive African fishes along different evolutionary paths 2Conquest of land began in shark genome 2Conquest of land began in shark genome 3'Western' diet linked to increased risk of colon cancer recurrence 2
50 ml Magnetic Separation Rack from New England Biolabs
TOPO Shotgun Subcloning Kit from Invitrogen
Gtporator (4 ml) from GEN-TREND s.r.o.
Apoptosis Sampler Kit from Cell Signaling Technology
Biology Products: